Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Total article views   HTML views PDF downloads Totals
13,877 Dovepress* 8,921+ 2,239 11,160
PubMed Central* 4,956 588 5,544
Totals 13,877 2,827 16,704
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar